Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chattem Counts On Extensions Across Core Brands For 2007 Growth

This article was originally published in The Tan Sheet

Executive Summary

Chattem will continue to launch line extensions to core brands as its primary revenue growth strategy in 2007 in the wake of the launch of the Icy Hot Pro-Therapy brace/therapeutic insert system, which so far has not met expectations

You may also be interested in...

Chattem Acquires “Great Brands” In Wake Of J&J’s Pfizer Purchase

Chattem said its past experience with brands such as Icy Hot and Selsun Blue will make for an easier transition of its newest package acquisition

Chattem Banks On “Best New Product Lineup” To Fuel 2006 Sales

Icy Hot and Selsun line extensions will drive 2006 top line growth in the 20-25% range and earnings growth to 10-15%, Chattem projects

Judge Orders FDA, Food Safety Group To Set FSMA Implementation Date

FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts